CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 93 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q2 2020. The put-call ratio across all filers is 0.10 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $12,202,000 | +56.5% | 113,059 | +68.7% | 1.82% | +93.3% |
| Q4 2019 | $7,799,000 | +108.6% | 67,019 | +105.2% | 0.94% | +145.8% |
| Q3 2019 | $3,738,000 | -21.7% | 32,657 | -37.6% | 0.38% | -10.5% |
| Q1 2019 | $4,776,000 | -26.4% | 52,349 | -38.7% | 0.43% | -69.0% |
| Q4 2018 | $6,485,000 | +459.1% | 85,436 | +489.2% | 1.38% | +727.5% |
| Q3 2018 | $1,160,000 | +233.3% | 14,500 | +314.3% | 0.17% | +247.9% |
| Q2 2018 | $348,000 | – | 3,500 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kite Lake Capital Management (UK) LLP | 207,382 | $24,135,000 | 76.46% |
| Maso Capital Partners Ltd | 539,597 | $62,798,000 | 20.20% |
| York Capital Management Global Advisors, LLC | 1,102,163 | $128,270,000 | 7.40% |
| HHLR ADVISORS, LTD. | 2,751,200 | $320,185,000 | 3.99% |
| Dalton Investments, Inc. | 15,551 | $1,810,000 | 1.14% |
| Athos Capital Ltd | 8,290 | $965,000 | 0.96% |
| Myriad Asset Management Ltd. | 67,019 | $7,799,000 | 0.94% |
| Temasek Holdings (Private) Ltd | 990,000 | $115,216,000 | 0.75% |
| OXFORD ASSET MANAGEMENT LLP | 211,646 | $24,631,000 | 0.68% |
| AGF Investments America Inc. | 12,230 | $1,423,000 | 0.47% |